Since 2014, we have led the effort to improve children's lives with polymeric transcatheter valves (PTV) for children. PTVs are easy to manufacture in pediatric and adult sizes, expandable to accommodate growth of children, and reduces a need for repeat open-heart surgeries.
Our aim is to transform the care of children with congenital heart disease by developing an entirely new generation of valves made of medical grade polymer devoid of any biological tissue. Commonly used valves thus far are made with biological tissue. Unfortunately, our immune system targets and destroys this biological tissue, sometimes rapidly, rendering the valve ineffective. Our approach will allow us to deliver these valves in a minimally invasive fashion, and extend the time between repeat open-heart surgeries.
What We've OBSERVED
CURRENT Tissue-Based Percutaneous Valves:
- Bulky size only suitable for teens and adult
- Expensive and difficult to manufacture from animal tissue
NEW Polymer-based valves:
- Easy to manufacture in pediatric and adult sizes
- Expandable to accommodate growth of children
- Reduces need for open-heart surgeries